| Date | Ticker | Price | Dir | Speaker | Thesis | Source |
|---|---|---|---|---|---|---|
| Feb 13 | SHORT | The rejection of Disc Medicines experimental compound for a rare and devastating disorder by the FDA is the latest example of the growing uncertainty at the nation’s top drug regulator https://t.co/6v |